324 results on '"Aureli, Massimo"'
Search Results
2. Gangliosides and Cell Surface Ganglioside Metabolic Enzymes in the Nervous System
3. GM1 oligosaccharide efficacy against α-synuclein aggregation and toxicity in vitro
4. Proceedings of workshop: “Neuroglycoproteins in health and disease”, INNOGLY cost action
5. Massive Accumulation of Sphingomyelin Affects the Lysosomal and Mitochondria Compartments and Promotes Apoptosis in Niemann-Pick Disease Type A
6. Gangliosides and Cell Surface Ganglioside Metabolic Enzymes in the Nervous System
7. Transcriptomic characterization of tissues from patients and subsequent pathway analyses reveal biological pathways that are implicated in spastic ataxia
8. LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson’s disease
9. Glycosphingolipids
10. Assessing the Potential of N-Butyl-l-deoxynojirimycin (l-NBDNJ) in Models of Cystic Fibrosis as a Promising Antibacterial Agent
11. Tezacaftor is a direct inhibitor of sphingolipid delta-4 desaturase enzyme (DEGS)
12. Phages as immunomodulators and their promising use as anti-inflammatory agents in a cftr loss-of-function zebrafish model
13. Glycans in autophagy, endocytosis and lysosomal functions
14. Lysosomes-neuronal degeneration in lysosomal storage disorders
15. Contributors
16. Turning the spotlight on the oligosaccharide chain of GM1 ganglioside
17. APOL1 polymorphism modulates sphingolipid profile of human podocytes
18. Sphingolipids and plasma membrane hydrolases in human primary bronchial cells during differentiation and their altered patterns in cystic fibrosis
19. Abiraterone and Ionizing Radiation Alter the Sphingolipid Homeostasis in Prostate Cancer Cells
20. Exploring the effect of chirality on the therapeutic potential of N-alkyl-deoxyiminosugars: anti-inflammatory response to Pseudomonas aeruginosa infections for application in CF lung disease
21. Glycosphingolipids
22. GM1 ganglioside exerts protective effects against glutamate‐excitotoxicity via its oligosaccharide in wild‐type and amyotrophic lateral sclerosis motor neurons
23. Cross‐talk between CFTR and sphingolipids in cystic fibrosis
24. The SPID-GBA study: Sex distribution, Penetrance, Incidence, and Dementia in GBA-PD
25. Neuronal membrane dynamics as fine regulator of sphingolipid composition
26. GM1 Oligosaccharide Efficacy in Parkinson’s Disease: Protection against MPTP
27. The combination elexacaftor/tezacaftor/ivacaftor (ETI) modulates the de novo synthethic pathway of ceramides in a genotype-independent manner
28. What the cell surface does not see: The gene vector under the protein corona
29. Gangliosides and Cell Surface Ganglioside Glycohydrolases in the Nervous System
30. Methods for Assay of Ganglioside Catabolic Enzymes
31. Serum Antibodies to Glycans in Peripheral Neuropathies
32. Aberrant Glycosphingolipid Expression and Membrane Organization in Tumor Cells: Consequences on Tumor–Host Interactions
33. Role of Gangliosides and Plasma Membrane-Associated Sialidase in the Process of Cell Membrane Organization
34. Evaluation of phages and liposomes as combination therapy to counteract Pseudomonas aeruginosa infection in wild-type and CFTR-null models
35. GM1 Ganglioside: Past Studies and Future Potential
36. The Role of 3-O-Sulfogalactosylceramide, Sulfatide, in the Lateral Organization of Myelin Membrane
37. Glycohydrolases in the central nervous system: the role of GBA2 in the neuronal differentiation
38. Metabolic Profile Variations along the Differentiation of Human-Induced Pluripotent Stem Cells to Dopaminergic Neurons
39. β-Glucocerebrosidase Deficiency Activates an Aberrant Lysosome-Plasma Membrane Axis Responsible for the Onset of Neurodegeneration
40. Therapeutic advantages of combined gene/cell therapy strategies in a murine model of GM2 gangliosidosis
41. Proceedings of workshop: “Neuroglycoproteins in health and disease”, INNOGLY cost action
42. Isolation and Analysis of Detergent-Resistant Membrane Fractions
43. Additional file 1 of Transcriptomic characterization of tissues from patients and subsequent pathway analyses reveal biological pathways that are implicated in spastic ataxia
44. Therapeutic advantages of combined gene/cell therapy strategies in a murine model of GM2 gangliosidosis
45. Exploring the link between ceramide and ionizing radiation
46. Chaperone Therapy for GM2 Gangliosidosis: Effects of Pyrimethamine on β-Hexosaminidase Activity in Sandhoff Fibroblasts
47. The Glycosphingolipid Hydrolases in the Central Nervous System
48. Lipid Rafts in Neurodegeneration and Neuroprotection
49. Fine tuning of cell functions through remodeling of glycosphingolipids by plasma membrane-associated glycohydrolases
50. The activities of LRRK2 and GCase are positively correlated in clinical biospecimens and experimental models of Parkinson’s disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.